Australia’s largest private health insurer, Medibank, has launched a first-of-its-kind funding program for MDMA-assisted therapy for PTSD as part of its ‘innovative psychotherapy program’. That makes it the first payor in the country to back psychedelic-assisted psychotherapy. The AUD $10 million (~USD $6.5 million) investment will fund patient access to MDMA therapy, as well as a long-term…
